UNITY BIOTECHNOLOGY INC's ticker is UBX and the CUSIP is 91381U101. A total of 92 filers reported holding UNITY BIOTECHNOLOGY INC in Q1 2021. The put-call ratio across all filers is 1.25 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $4,000 | -84.6% | 10,655 | -54.1% | 0.00% | – |
Q1 2022 | $26,000 | -80.3% | 23,200 | -74.3% | 0.00% | – |
Q4 2021 | $132,000 | +5.6% | 90,164 | +116.3% | 0.00% | – |
Q3 2021 | $125,000 | -62.6% | 41,681 | -42.1% | 0.00% | – |
Q2 2021 | $334,000 | -20.1% | 72,012 | +3.6% | 0.00% | – |
Q1 2021 | $418,000 | -38.4% | 69,537 | -46.3% | 0.00% | – |
Q4 2020 | $679,000 | +234.5% | 129,542 | +121.1% | 0.00% | – |
Q3 2020 | $203,000 | -62.5% | 58,577 | -6.0% | 0.00% | – |
Q2 2020 | $541,000 | +42.7% | 62,334 | -4.4% | 0.00% | – |
Q1 2020 | $379,000 | -42.5% | 65,234 | -28.6% | 0.00% | – |
Q4 2019 | $659,000 | +42.3% | 91,373 | +20.5% | 0.00% | – |
Q3 2019 | $463,000 | -85.1% | 75,834 | -76.7% | 0.00% | -100.0% |
Q2 2019 | $3,097,000 | +12.3% | 325,954 | -4.2% | 0.00% | 0.0% |
Q1 2019 | $2,758,000 | -66.9% | 340,099 | -33.7% | 0.00% | -66.7% |
Q4 2018 | $8,343,000 | +3.1% | 513,082 | +3.3% | 0.00% | +50.0% |
Q3 2018 | $8,091,000 | +0.3% | 496,672 | -7.3% | 0.00% | 0.0% |
Q2 2018 | $8,068,000 | – | 535,686 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Mayo Clinic | 1,571,981 | $9,117,000 | 23.05% |
Invus Financial Advisors, LLC | 2,189,998 | $12,702,000 | 6.24% |
Leap Investments LP | 13,400 | $78,000 | 0.11% |
Moloney Securities Asset Management, LLC | 51,950 | $301,000 | 0.11% |
Verity Asset Management, Inc. | 14,748 | $86,000 | 0.11% |
Virtus ETF Advisers LLC | 43,010 | $249,000 | 0.10% |
Investors Financial Group, LLC | 15,850 | $92,000 | 0.09% |
SUNFLOWER BANK, NA WEALTH MANAGEMENT | 20,000 | $116,000 | 0.04% |
Baillie Gifford | 3,803,014 | $22,057,000 | 0.02% |
JACOBS LEVY EQUITY MANAGEMENT, INC | 315,047 | $1,827,000 | 0.02% |